Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection
暂无分享,去创建一个
S. Lewin | K. Ruxrungtham | D. Cooper | S. Kent | S. Sirivichayakul | G. Dore | P. Revill | P. Desmond | J. Sasadeusz | A. Avihingsanon | P. Cameron | G. Matthews | P. Marks | J. Slavin | J. Chang | A. Thompson | S. Locarnini | S. Buranapraditkun | D. Iser | Gregory J. Dore | Paul U. Cameron | Sharon R. Lewin | Stephen J. Kent | David A. Cooper | J. Judy Chang
[1] R. Kaul,et al. HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection , 2008, PloS one.
[2] S. Ray,et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. , 2008, Gastroenterology.
[3] V. Appay,et al. CD8+ T cell efficacy in vaccination and disease , 2008, Nature Medicine.
[4] S. Lewin,et al. The phenotype of hepatitis B virus–specific T cells differ in the liver and blood in chronic hepatitis B virus infection , 2007, Hepatology.
[5] David A. Price,et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.
[6] G. Dore,et al. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database , 2007, Journal of gastroenterology and hepatology.
[7] M. Chevallier,et al. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] F. Carrat,et al. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY) , 2007, AIDS.
[9] C. Thio,et al. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. , 2007, The Lancet. Infectious diseases.
[10] P. Borrow,et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage , 2007, The Journal of experimental medicine.
[11] A. Bertoletti,et al. Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.
[12] S. Lewin,et al. Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.
[13] Todd M. Allen,et al. Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection , 2006, PLoS medicine.
[14] V. Soriano,et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. , 2006, AIDS research and human retroviruses.
[15] O. Kirk,et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. , 2006, Archives of internal medicine.
[16] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[17] H. Janssen,et al. Different composition of intrahepatic lymphocytes in the immune‐tolerance and immune‐clearance phase of chronic hepatitis B , 2006, Journal of medical virology.
[18] P. Klenerman,et al. Diminished frequency of hepatitis C virus specific interferon γ secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients , 2006, Gut.
[19] G. Pantaleo,et al. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Mocroft,et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.
[21] S. Lewin,et al. Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy , 2005, Journal of Virology.
[22] K. Sherman,et al. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. , 2005, The Journal of infectious diseases.
[23] B. Walker,et al. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. , 2005, Blood.
[24] A. Wohl,et al. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study , 2004, AIDS.
[25] R. Horsburgh,et al. Comparison of HCV‐specific intrahepatic CD4+ T cells in HIV/HCV versus HCV , 2004, Hepatology.
[26] Geoffrey Dusheiko,et al. Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.
[27] K. Ruxrungtham,et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort , 2004, AIDS.
[28] G. Pantaleo,et al. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. , 2004, Blood.
[29] Ding‐Shinn Chen,et al. Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. , 2003, Journal of hepatology.
[30] G. Bren,et al. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. , 2003, The Journal of infectious diseases.
[31] R. D. de Man,et al. The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy technique. , 2003, FEMS immunology and medical microbiology.
[32] K. Ruxrungtham,et al. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001 , 2003, AIDS.
[33] A. McNaghten,et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. , 2003, The Journal of infectious diseases.
[34] S. Lewin,et al. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV–HBV co-infected individuals , 2003, AIDS.
[35] K. Petoumenos,et al. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy , 2003, HIV medicine.
[36] P. Zondervan,et al. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection , 2003, Journal of viral hepatitis.
[37] M. Altfeld,et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. , 2003, Journal of immunological methods.
[38] Urs Christen,et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.
[39] J. Sasadeusz,et al. Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[40] Martin A. Nowak,et al. Compromised Influenza Virus-Specific CD8+-T-Cell Memory in CD4+-T-Cell-Deficient Mice , 2002, Journal of Virology.
[41] J. Phair,et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.
[42] S. Oka,et al. Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS. , 2001, AIDS research and human retroviruses.
[43] R. Koup,et al. Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production. , 2001, Immunology letters.
[44] D. Wohl,et al. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. , 2001, The Journal of infectious diseases.
[45] B. Walker,et al. Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus , 2001, Journal of Virology.
[46] D. Snydman,et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] M. Mulligan,et al. A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon , 2000, Journal of Virology.
[48] J. Lieberman,et al. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. , 2000, Blood.
[49] F. Donato,et al. Mortality for liver disease in patients with HIV infection: a cohort study. , 2000, Journal of acquired immune deficiency syndromes.
[50] D. Vergani,et al. The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection , 2000, The Journal of experimental medicine.
[51] M. Loriot,et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.
[52] Gerken,et al. HBV‐specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro‐ and anti‐inflammatory cytokines , 1999, Clinical and experimental immunology.
[53] G. Gerken,et al. The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. , 1999, Journal of hepatology.
[54] M. Chen,et al. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. , 1998, Journal of immunology.
[55] J. Lieberman,et al. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. , 1998, Blood.
[56] C. Kurts,et al. CD4+ T Cell Help Impairs CD8+ T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity , 1997, The Journal of experimental medicine.
[57] F. Su,et al. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Manns,et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. , 1997, Journal of hepatology.
[59] P. Angus,et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. , 1997, Journal of hepatology.
[60] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[61] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[62] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[63] L. Mayer,et al. Inhibition of HIV‐1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-α , 1992 .
[64] L. Mayer,et al. Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha. , 1992, AIDS.
[65] F. Chisari,et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen , 1991, The Journal of experimental medicine.
[66] A Valli,et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.
[67] F. Miedema,et al. Selective loss of T cell functions in different stages of HIV infection Early loss ofanti‐CD3‐induced T cell proliferation followed by decreased anti‐CD3‐induced cytotoxic T lymphocyte generation in AIDS‐related complex and AIDS , 1990, European journal of immunology.
[68] D. Fish,et al. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. , 1990, Journal of clinical pathology.